These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 6138647)

  • 21. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class II HLA-DR antigens on non-autoimmune human thyroid cells stimulate autologous T cells with high suppressor activity.
    Lahat N; Sheinfeld M; Sobel E; Baron E; Kraiem Z
    Autoimmunity; 1990; 8(2):125-33. PubMed ID: 2151759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autoimmune polyendocrinopathies. Pathogenic hypotheses].
    Scherbaum WA; Youinou P; Tater D; Jouquan J; Pujol-Borrell R; Bercovici JP; Bottazzo GF
    Ann Endocrinol (Paris); 1986; 47(6):420-8. PubMed ID: 3827197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma induces HLA-DR expression by thyroid epithelium.
    Todd I; Pujol-Borrell R; Hammond LJ; Bottazzo GF; Feldmann M
    Clin Exp Immunol; 1985 Aug; 61(2):265-73. PubMed ID: 3930110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.
    Cavalli G; Hayashi M; Jin Y; Yorgov D; Santorico SA; Holcomb C; Rastrou M; Erlich H; Tengesdal IW; Dagna L; Neff CP; Palmer BE; Spritz RA; Dinarello CA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1363-8. PubMed ID: 26787888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.
    Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD
    Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mimicry and autoimmunity.
    Rojas M; Restrepo-Jiménez P; Monsalve DM; Pacheco Y; Acosta-Ampudia Y; Ramírez-Santana C; Leung PSC; Ansari AA; Gershwin ME; Anaya JM
    J Autoimmun; 2018 Dec; 95():100-123. PubMed ID: 30509385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infections and autoimmune endocrine disease.
    Tomer Y; Davies TF
    Baillieres Clin Endocrinol Metab; 1995 Jan; 9(1):47-70. PubMed ID: 7726798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The viral enterprises in autoimmunity: conversion of target cells into de novo APCs is the presage to autoimmunity.
    Temajo NO; Howard N
    Autoimmun Rev; 2012 Jul; 11(9):653-8. PubMed ID: 22122867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II.
    Ballotti S; Chiarelli F; de Martino M
    Horm Res; 2006; 66(3):142-52. PubMed ID: 16807509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA class II peptide-binding and autoimmunity.
    Gebe JA; Swanson E; Kwok WW
    Tissue Antigens; 2002 Feb; 59(2):78-87. PubMed ID: 12028533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmunity in endocrine diseases.
    Rose NR; Burek CL
    Spec Top Endocrinol Metab; 1982; 4():139-76. PubMed ID: 6304927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction.
    Khoury EL; Pereira L; Greenspan FS
    Am J Pathol; 1991 May; 138(5):1209-23. PubMed ID: 1850961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network regulation of autoimmunity: an automation model.
    Cohen IR; Atlan H
    J Autoimmun; 1989 Oct; 2(5):613-25. PubMed ID: 2572229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histocompatibility antigens and autoimmune diseases].
    Pérez González J; Sarriá A; Legido A; Ventura P; Larrad L
    An Esp Pediatr; 1985 Aug; 23(2):112-6. PubMed ID: 3864387
    [No Abstract]   [Full Text] [Related]  

  • 36. Autoimmune endocrine disease.
    Anderson MS
    Curr Opin Immunol; 2002 Dec; 14(6):760-4. PubMed ID: 12413526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma.
    Chiovato L; Lapi P; Mariotti S; Del Prete G; De Carli M; Pinchera A
    J Clin Endocrinol Metab; 1994 Aug; 79(2):653-6. PubMed ID: 7913937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
    Muixí L; Alvarez I; Jaraquemada D
    Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell activation and antigen presentation in human thyroid autoimmunity.
    Feldmann M; Dayan C; Rapoport B; Londei M
    J Autoimmun; 1992 Apr; 5 Suppl A():115-21. PubMed ID: 1503607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The complex role of epithelial cell MHC class II antigen expression in autoimmune endocrine disease.
    Davies TF
    Autoimmunity; 1990; 8(2):87-9. PubMed ID: 2104190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.